Projects

  • Snakebite Treatment and Prevention
  • Access to Insulin
  • Medicines in Europe
  • Prices, Availability & Affordability
  • Artificial Intelligence and Medicines
  • Sexual and Reproductive Health
  • Supporting Healthy Adolescents
  • Resources
  • Publications
  • Politics Of Medicines Encyclopaedia
  • COVID-19 Response
  • Partners for Change
  • En français: Santé sexuelle et reproductive
  • Soutenir la santé des adolescents

Work With Us

  • Partners
  • Access to Medicine Movement
  • Jobs
  • Media
  • News
  • Media Resource
  • Blog Posts
  • Events

About

  • Mission, vision, core principles & impact
  • Financial info, statutes, policies & governance
  • Team
  • Testimonials
  • Contact us

Support our projects

Donate Join the Movement
AAA
Health Action International
  • Publications
  • News

Donate

Projects

  • Snakebite Treatment and Prevention
  • Access to Insulin
  • Medicines in Europe
  • Prices, Availability & Affordability
  • Artificial Intelligence and Medicines
  • Sexual and Reproductive Health
  • Supporting Healthy Adolescents
  • Resources
  • Publications
  • Politics Of Medicines Encyclopaedia
  • COVID-19 Response
  • Partners for Change
  • En français: Santé sexuelle et reproductive
  • Soutenir la santé des adolescents

Work With Us

  • Partners
  • Access to Medicine Movement
  • Jobs
  • Media
  • News
  • Media Resource
  • Blog Posts
  • Events

About

  • Mission, vision, core principles & impact
  • Financial info, statutes, policies & governance
  • Team
  • Testimonials
  • Contact us

Support our projects

Donate Join the Movement

Corporate funding linked to EU patient & consumer groups policy

Home > News > Corporate funding linked to EU patient & consumer groups policy

Share via:

  • Facebook
  • Twitter
  • LinkedIn
  • More

HAI Europe’s latest research has established a link between patient and consumer groups’ perspectives on EU medicines policies and the funding they receive from the pharmaceutical industry.


Please see our Press Release, as well as the two-page Factsheet and complete Research Article (links to website)

Tags
  • Civil Society
  • Conflicts of Interest
  • Medicines in Europe
Print or PDF
Print this page
Download this page

Related News

  • HAI Europe survey reveals new data on financial transparency of patient and consumer organisations
  • EU lobby transparency book launch by ALTER-EU
  • EU Global Health Communication
  • Patient Groups need dose of transparency
  • Patient advocacy groups: another tool to boost compliance?
  • Medicines manufacturers have clear motives for financing the patient voice
  • Public Event on EU-MERCOSUR in Buenos Aires
  • EU Global Health Council Conclusions presented at WHA
  • Finnish study: Drug companies see added value of patient group sponsorship
  • EU Policy Opportunities in Biomedical Innovation and the Public Good
Join the movement

Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere

Donate Become a Member

Projects
  • Snakebite Treatment and Prevention
  • Access to Insulin
  • Sexual and Reproductive Health
  • Medicines in Europe
  • Prices, Availability & Affordability
  • Artificial Intelligence and Medicines
  • Supporting Healthy Adolescents
About Us
  • Vision, Mission & Impact
  • History
  • Governance
Work With Us
  • Donate
  • Partner with us
  • Jobs & Internships
Contact Us

Health Action International
Overtoom 60 (2)
1054 HK Amsterdam

The Netherlands

+31 (0) 20 412 4523
info@haiweb.org

© 2023 Health Action International
  •  
Share via
Facebook
Twitter
LinkedIn
Mix
Email
Print
Copy Link
Powered by Social Snap
Copy link
CopyCopied
Powered by Social Snap